# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-022228
Filing Date
2023-02-15
Accepted
2023-02-15 08:19:39
Documents
1
Period of Report
2022-09-30
Effectiveness Date
2023-02-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm233336d2_ars.pdf | ARS | 1927027
| Complete submission text file | 0001104659-23-022228.txt |  | 2390132

Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: ARS | Act: 34 | File No.: 001-37759 | Film No.: 23633706
SIC: 2836 Biological Products, (No Diagnostic Substances)